Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Renal Cell (Clear Cell Only)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT04696731
What this trial is testing

Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Advanced/Metastatic Clear Cell Renal Cell Carcinoma
Allogene Therapeutics 120
Testing effectiveness (Phase 2)Looking for participantsNCT06690697
What this trial is testing

Combination of Toripalimab and JS004 Therapy for ccRCC

Who this might be right for
Clear Cell Renal Cell Carcinoma
Fudan University 80
Testing effectiveness (Phase 2)Ended earlyNCT04267120
What this trial is testing

Lenvatinib (LEN) in Combination With Pembrolizumab (KEYtruda) in Subjects With Locally Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma (The LENKYN Trial)

Who this might be right for
Renal Cell Carcinoma
Washington University School of Medicine 11
Testing effectiveness (Phase 2)Study completedNCT06389682
What this trial is testing

Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM005 in Patients

Who this might be right for
Clear Cell Renal Cell Carcinoma Metastatic
Norroy Bioscience Co., LTD 19
Testing effectiveness (Phase 2)UnknownNCT05879471
What this trial is testing

68Ga-NY104 PET/CT in Patients With Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
Peking Union Medical College Hospital 39
Very early researchWithdrawnNCT06708936
What this trial is testing

KSD-201 Treatment for Advanced Clear Cell Renal Cell Carcinoma: an Early Exploratory Clinical Study

Who this might be right for
Clear Cell Renal Cell Carcinoma (ccRCC)
Kousai Bio Co., Ltd.
Testing effectiveness (Phase 2)Study completedNCT00688753
What this trial is testing

RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in Europe

Who this might be right for
CarcinomaRenal CellNon Clear Cell Renal Carcinoma+2 more
Novartis Pharmaceuticals 92
Testing effectiveness (Phase 2)Study completedNCT02667886
What this trial is testing

Trial of X4P-001 in Participants With Advanced Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
X4 Pharmaceuticals 74
Testing effectiveness (Phase 2)Study completedNCT01727089
What this trial is testing

Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CarcinomaStage IV Renal Cell Cancer+2 more
National Cancer Institute (NCI) 59
Testing effectiveness (Phase 2)Active Not RecruitingNCT04802876
What this trial is testing

Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors

Who this might be right for
MSI-H Colorectal CancerMelanomaAnal Carcinoma+28 more
SOLTI Breast Cancer Research Group 184
Large-scale testing (Phase 3)Study completedNCT00002611
What this trial is testing

Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer

Who this might be right for
Kidney Cancer
Children's Oncology Group 3,031
Testing effectiveness (Phase 2)Active Not RecruitingNCT06035224
What this trial is testing

Cadonilimab (AK104) Plus Lenvatinib in Previously Immunotherapy-Treated Advanced/Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
RenJi Hospital 28
Testing effectiveness (Phase 2)Looking for participantsNCT07187778
What this trial is testing

Phase II Trial of Single Agent Belzutifan or Pembrolizumab Versus Combination as Neoadjuvant Therapy in Clear Cell Renal Cell Carcinoma (BLAZE)

Who this might be right for
Clear Cell Renal Cell Carcinoma
M.D. Anderson Cancer Center 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07578025
What this trial is testing

Zanzalintinib and MO-03 for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy

Who this might be right for
Metastatic Clear Cell Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8
City of Hope Medical Center 34
Early research (Phase 1)Not Yet RecruitingNCT07828249
What this trial is testing

Phase I Study Evaluating 161Tb-PSMA Therapy in Adult Patients With Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
Centre Leon Berard 26
Testing effectiveness (Phase 2)Looking for participantsNCT07386158
What this trial is testing

Pucotenlimab Combination With Vorolanib as Neoadjuvant Therapy for ccRCC

Who this might be right for
VorolanibClear Cell Renal Cell Carcinoma (ccRCC)Neoadjuvant Therapy
Sun Yat-sen University 21
Testing effectiveness (Phase 2)Looking for participantsNCT06794229
What this trial is testing

Neoadjuvant Zanzalintinib Plus Nivolumab in Patients With Locally Advanced and/or Inoperable Clear Cell Renal Cell Carcinoma With or Without Non-measurable Metastasis

Who this might be right for
Locally Advanced Renal Cell Carcinoma
Qian Qin 69
Testing effectiveness (Phase 2)UnknownNCT04958473
What this trial is testing

Sintilimab in Combination With Axitinib in Advanced Renal Cell Cancer

Who this might be right for
Renal Cell CarcinomaClear Cell Renal Cell Carcinoma
Tianjin Medical University Second Hospital 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07256223
What this trial is testing

A Clinical Trial of Envafolimab Combined With Lenvatinib for Kidney Cancer With Liver Spread

Who this might be right for
Clear Cell Renal Cell Cancer (ccRCC)Liver Metastasis
Fudan University 30
Early research (Phase 1)Active Not RecruitingNCT05581004
What this trial is testing

Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid TumorsNSCLCHNSCC+9 more
Genentech, Inc. 165
Next Page